CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: sertraline
Accession: CHEBI:9123
browse the term
Definition: A member of the class of tetralins that is tetralin which is substituted at positions 1 and 4 by a methylamino and a 3,4-dichlorophenyl group, respectively (the S,S diastereoisomer). A selective serotonin-reuptake inhibitor (SSRI), it is administered orally as the hydrochloride salt as an antidepressant for the treatment of depression, obsessive-compulsive disorder, panic disorder and post-traumatic stress disorder.
Synonyms: exact_synonym: (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine
related_synonym: (1S,4S)-sertraline; (1S-cis)-1,2,3,4-tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine; CP 51974; Formula=C17H17Cl2N; InChI=1S/C17H17Cl2N/c1-20-17-9-7-12(13-4-2-3-5-14(13)17)11-6-8-15(18)16(19)10-11/h2-6,8,10,12,17,20H,7,9H2,1H3/t12-,17-/m0/s1; InChIKey=VGKDLMBJGBXTGI-SJCJKPOMSA-N; SMILES=[H][C@]1(CC[C@H](NC)c2ccccc12)c1ccc(Cl)c(Cl)c1; cis-(+)-sertraline; sertralina; sertralinum
xref: CAS:79617-96-2; DrugBank:DB01104; Drug_Central:2436; HMDB:HMDB0005010; KEGG:C07246; KEGG:D02360; LINCS:LSM-3843
xref_mesh: MESH:D020280
xref: PDBeChem:SRE; PMID:19502000; PMID:21823671; Patent:US4536518; Reaxys:5753709; Wikipedia:Sertraline
cyclic_relationship: is_conjugate_base_of CHEBI:64214
G
Abcb1a
ATP binding cassette subfamily B member 1A
increases activity
ISO
Sertraline results in increased activity of ABCB1 protein
CTD
PMID:23273999
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Acaca
acetyl-CoA carboxylase alpha
increases phosphorylation
ISO
Sertraline results in increased phosphorylation of ACACA protein
CTD
PMID:33124469
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
G
Akt1
AKT serine/threonine kinase 1
multiple interactions
EXP
Sertraline inhibits the reaction [INS protein results in increased phosphorylation of and results in increased activity of AKT1 protein]
CTD
PMID:17728140
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Alb
albumin
affects binding
ISO
Sertraline binds to ALB protein
CTD
PMID:26471709
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Asah1
N-acylsphingosine amidohydrolase 1
increases expression
ISO
Sertraline results in increased expression of ASAH1 mRNA
CTD
PMID:15342952
NCBI chr16:50,966,404...50,997,827
Ensembl chr16:50,966,229...51,008,233
G
Asns
asparagine synthetase (glutamine-hydrolyzing)
increases expression
ISO
Sertraline results in increased expression of ASNS mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
G
Atf2
activating transcription factor 2
increases expression
ISO
Sertraline results in increased expression of ATF2 mRNA
CTD
PMID:24865413
NCBI chr 3:58,718,323...58,795,280
Ensembl chr 3:58,718,332...58,795,236
G
Atf4
activating transcription factor 4
increases expression
ISO
Sertraline results in increased expression of ATF4 protein
CTD
PMID:24865413
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
G
Bcl2
BCL2, apoptosis regulator
affects expression decreases expression
ISO
Sertraline affects the expression of BCL2 protein Sertraline results in decreased expression of BCL2 protein
CTD
PMID:18403212 PMID:24194395
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bdnf
brain-derived neurotrophic factor
increases expression
ISO
Sertraline results in increased expression of BDNF protein
CTD
PMID:18403212
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
Casp3
caspase 3
multiple interactions increases activity
ISO
4-phenylbutyric acid inhibits the reaction [Sertraline results in increased activity of CASP3 protein]; Sertraline results in increased cleavage of and results in increased activity of CASP3 protein
CTD
PMID:24194395 PMID:24865413
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp4
caspase 4
increases cleavage multiple interactions
ISO
Sertraline results in increased cleavage of CASP4 protein MAP4K4 mutant form inhibits the reaction [Sertraline results in increased cleavage of CASP4 protein]
CTD
PMID:24865413
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
G
Casp7
caspase 7
multiple interactions increases activity
ISO
4-phenylbutyric acid inhibits the reaction [Sertraline results in increased activity of CASP7 protein]
CTD
PMID:24865413
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
G
Casp9
caspase 9
multiple interactions
ISO
Sertraline results in increased cleavage of and results in increased activity of CASP9 protein
CTD
PMID:24194395
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
multiple interactions
EXP
Nitric Oxide promotes the reaction [Sertraline inhibits the reaction [3-nitropropionic acid results in decreased activity of CAT protein]]; Sertraline inhibits the reaction [3-nitropropionic acid results in decreased activity of CAT protein]
CTD
PMID:20305041
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cd14
CD14 molecule
decreases expression
ISO
Sertraline results in decreased expression of CD14 mRNA
CTD
PMID:24865413
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
G
Creb1
cAMP responsive element binding protein 1
increases expression
EXP
Sertraline results in increased expression of CREB1 mRNA
CTD
PMID:8601816
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
G
Crh
corticotropin releasing hormone
multiple interactions
ISO
[Cannabidiol co-treated with Sertraline] results in decreased expression of CRH mRNA
CTD
PMID:34262461
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
G
Cryaa
crystallin, alpha A
increases expression
ISO
Sertraline results in increased expression of CRYAA mRNA
CTD
PMID:24865413
NCBI chr20:9,783,605...9,787,351
Ensembl chr20:9,783,605...9,787,349
G
Cul1
cullin 1
decreases expression
ISO
Sertraline results in decreased expression of CUL1 mRNA
CTD
PMID:24865413
NCBI chr 4:76,551,952...76,625,830
Ensembl chr 4:76,551,983...76,627,980
G
Cyp11a1
cytochrome P450, family 11, subfamily a, polypeptide 1
decreases expression
EXP
Sertraline results in decreased expression of CYP11A1 mRNA
CTD
PMID:29850907
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
G
Cyp17a1
cytochrome P450, family 17, subfamily a, polypeptide 1
decreases expression
EXP
Sertraline results in decreased expression of CYP17A1 mRNA
CTD
PMID:29850907
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
decreases activity
ISO
Sertraline results in decreased activity of CYP19A1 protein
CTD
PMID:26162595
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
multiple interactions decreases activity
ISO
[Sertraline results in decreased activity of CYP2B6 protein] which results in decreased metabolism of Bupropion; CYP2B6 protein results in decreased methylation of and results in increased metabolism of Sertraline
CTD
PMID:15547048 PMID:26599973
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
affects metabolic processing increases metabolic processing decreases methylation multiple interactions
ISO
CYP2C19 gene polymorphism affects the metabolism of Sertraline CYP2C19 protein results in increased metabolism of Sertraline CYP2C19 protein results in decreased methylation of Sertraline CYP2C19 protein results in decreased amination of and results in increased metabolism of Sertraline; CYP2C19 protein results in decreased methylation of and results in increased metabolism of Sertraline
CTD
PMID:11452243 PMID:15547048
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
multiple interactions
ISO
CYP2D6 protein results in decreased methylation of and results in increased metabolism of Sertraline
CTD
PMID:15547048
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions
ISO
CYP3A4 protein results in decreased amination of and results in increased metabolism of Sertraline; CYP3A4 protein results in decreased methylation of and results in increased metabolism of Sertraline; Sertraline promotes the reaction [CYP3A4 protein results in increased oxidation of 7-benzyloxy-4-trifluoromethylcoumarin]
CTD
PMID:15547048 PMID:19299527
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Dbh
dopamine beta-hydroxylase
increases response to substance
ISO
DBH protein results in increased susceptibility to Sertraline
CTD
PMID:15148402
NCBI chr 3:10,488,260...10,505,245
Ensembl chr 3:10,488,260...10,505,248
G
Ddit3
DNA-damage inducible transcript 3
multiple interactions increases expression
ISO
4-phenylbutyric acid inhibits the reaction [Sertraline results in increased expression of DDIT3 protein]; MAP4K4 mutant form inhibits the reaction [Sertraline results in increased expression of DDIT3 protein] Sertraline results in increased expression of DDIT3 mRNA; Sertraline results in increased expression of DDIT3 protein
CTD
PMID:24865413
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Depp1
DEPP autophagy regulator 1
increases expression
ISO
Sertraline results in increased expression of DEPP1 mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr 4:149,910,794...149,913,013
Ensembl chr 4:149,910,779...149,914,542
G
Dnajc5
DnaJ heat shock protein family (Hsp40) member C5
increases expression
ISO
Sertraline results in increased expression of DNAJC5 mRNA; Sertraline results in increased expression of DNAJC5 protein
CTD
PMID:11257428
NCBI chr 3:168,621,905...168,656,570
Ensembl chr 3:168,621,969...168,655,935
G
Drd1
dopamine receptor D1
increases expression
EXP
Sertraline results in increased expression of DRD1 mRNA
CTD
PMID:16499906
NCBI chr17:10,540,440...10,544,971
Ensembl chr17:10,540,558...10,545,002
G
Dusp1
dual specificity phosphatase 1
increases expression
ISO
Sertraline results in increased expression of DUSP1 mRNA
CTD
PMID:24865413
NCBI chr10:16,680,478...16,683,275
G
Dusp10
dual specificity phosphatase 10
increases expression
ISO
Sertraline results in increased expression of DUSP10 mRNA
CTD
PMID:24865413
NCBI chr13:95,613,716...95,651,716
Ensembl chr13:95,614,292...95,651,716
G
Dusp14
dual specificity phosphatase 14
increases expression
ISO
Sertraline results in increased expression of DUSP14 mRNA
CTD
PMID:24865413
NCBI chr10:68,936,483...68,966,347
Ensembl chr10:68,935,330...68,965,329
G
Dusp16
dual specificity phosphatase 16
increases expression
ISO
Sertraline results in increased expression of DUSP16 mRNA
CTD
PMID:24865413
NCBI chr 4:167,546,780...167,630,173
Ensembl chr 4:167,548,155...167,629,980
G
Dusp8
dual specificity phosphatase 8
increases expression
ISO
Sertraline results in increased expression of DUSP8 mRNA
CTD
PMID:24865413
NCBI chr 1:197,167,392...197,184,285
Ensembl chr 1:197,169,422...197,182,921
G
Egfr
epidermal growth factor receptor
increases expression
ISO
Sertraline results in increased expression of EGFR mRNA
CTD
PMID:24865413
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
G
Eif2ak3
eukaryotic translation initiation factor 2 alpha kinase 3
multiple interactions increases expression
ISO
MAP4K4 mutant form inhibits the reaction [Sertraline results in increased phosphorylation of EIF2AK3 protein]; Sertraline results in increased expression of and results in increased phosphorylation of EIF2AK3 protein Sertraline results in increased expression of EIF2AK3 mRNA
CTD
PMID:24865413
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
G
Eif2s1
eukaryotic translation initiation factor 2 subunit alpha
increases phosphorylation
ISO
Sertraline results in increased phosphorylation of EIF2S1 protein
CTD
PMID:24865413
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
G
Ern1
endoplasmic reticulum to nucleus signaling 1
increases expression
ISO
Sertraline results in increased expression of ERN1 mRNA
CTD
PMID:24865413
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
G
Fabp1
fatty acid binding protein 1
increases expression
ISO
Sertraline results in increased expression of FABP1 mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788
G
Fndc4
fibronectin type III domain containing 4
increases expression
ISO
Sertraline results in increased expression of FNDC4 mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr 6:25,077,155...25,080,812
Ensembl chr 6:25,077,349...25,080,675
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
decreases expression increases expression
EXP ISO
Sertraline results in decreased expression of FOS mRNA Sertraline results in increased expression of FOS mRNA
CTD
PMID:7612155 PMID:24865413
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
increases expression
ISO
Sertraline results in increased expression of GADD45A mRNA
CTD
PMID:24865413
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
G
Gadd45b
growth arrest and DNA-damage-inducible, beta
increases expression
ISO
Sertraline results in increased expression of GADD45B mRNA
CTD
PMID:24865413
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
G
Gdpd3
glycerophosphodiester phosphodiesterase domain containing 3
increases expression
ISO
Sertraline results in increased expression of GDPD3 mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr 1:181,373,505...181,383,063
Ensembl chr 1:181,366,626...181,383,063
G
Herpud1
homocysteine inducible ER protein with ubiquitin like domain 1
increases expression
ISO
Sertraline results in increased expression of HERPUD1 mRNA
CTD
PMID:24865413
NCBI chr19:10,598,411...10,609,002
Ensembl chr19:10,598,417...10,618,424
G
Hpn
hepsin
increases expression
ISO
Sertraline results in increased expression of HPN mRNA
CTD
PMID:15342952
NCBI chr 1:86,337,085...86,352,785
Ensembl chr 1:86,337,087...86,352,811
G
Hsd3b1
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
decreases expression
EXP
Sertraline results in decreased expression of HSD3B1 mRNA
CTD
PMID:29850907
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
increases expression
ISO
Sertraline results in increased expression of HSPA1A mRNA
CTD
PMID:24865413
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
G
Hspa1b
heat shock protein family A (Hsp70) member 1B
increases expression
ISO
Sertraline results in increased expression of HSPA1B mRNA
CTD
PMID:24865413
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
G
Hspa6l-ps1
heat shock protein family A (Hsp70) member 6 like, pseudogene 1
increases expression
ISO
Sertraline results in increased expression of HSPA6 mRNA
CTD
PMID:24865413
NCBI chr13:83,273,176...83,274,317
G
Hspa8
heat shock protein family A (Hsp70) member 8
increases expression decreases expression
EXP ISO
Sertraline results in increased expression of HSPA8 mRNA alternative form; Sertraline results in increased expression of HSPA8 protein alternative form Sertraline results in decreased expression of HSPA8 mRNA
CTD
PMID:10425221 PMID:24865413
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
G
Htr1a
5-hydroxytryptamine receptor 1A
multiple interactions increases expression
EXP
[Estradiol co-treated with Sertraline] affects the expression of HTR1A mRNA Sertraline results in increased expression of HTR1A mRNA
CTD
PMID:18650020
NCBI chr 2:36,693,462...36,698,026
Ensembl chr 2:36,694,174...36,695,442
G
Htr2a
5-hydroxytryptamine receptor 2A
multiple interactions increases expression
EXP
[Estradiol co-treated with Sertraline] affects the expression of HTR2A mRNA; Estradiol promotes the reaction [Sertraline results in increased expression of HTR2A mRNA]
CTD
PMID:18650020
NCBI chr15:49,950,035...50,022,188
Ensembl chr15:49,950,804...50,020,928
G
Htr2c
5-hydroxytryptamine receptor 2C
multiple interactions increases expression
EXP
[Estradiol co-treated with Sertraline] affects the expression of HTR2C mRNA; Estradiol promotes the reaction [Sertraline results in increased expression of HTR2C mRNA]
CTD
PMID:18650020
NCBI chr X:110,640,777...110,870,288
Ensembl chr X:110,641,153...110,870,287
G
Inhbe
inhibin subunit beta E
increases expression
ISO
Sertraline results in increased expression of INHBE mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr 7:63,176,221...63,179,209
Ensembl chr 7:63,176,219...63,179,172
G
Ins1
insulin 1
multiple interactions
EXP
[Sertraline binds to 2-Hydroxypropyl-beta-cyclodextrin] inhibits the reaction [Alloxan results in decreased expression of INS1 protein]; Sertraline inhibits the reaction [Alloxan results in decreased expression of INS1 protein]
CTD
PMID:26593071
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
G
Ins2
insulin 2
multiple interactions
EXP
Sertraline affects the reaction [INS protein affects the phosphorylation of IRS1 protein]; Sertraline inhibits the reaction [INS protein results in increased phosphorylation of and results in increased activity of AKT1 protein]
CTD
PMID:17728140
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
G
Irs1
insulin receptor substrate 1
multiple interactions decreases activity
EXP
Sertraline affects the reaction [INS protein affects the phosphorylation of IRS1 protein] Sertraline results in decreased activity of IRS1 protein
CTD
PMID:17728140
NCBI chr 9:83,552,964...83,605,797
Ensembl chr 9:83,548,944...83,606,122
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
multiple interactions increases expression
ISO
Sertraline results in increased expression of and results in increased phosphorylation of JUN protein Sertraline results in increased expression of JUN mRNA
CTD
PMID:24194395 PMID:24865413
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Jund
JunD proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Sertraline results in increased expression of JUND mRNA
CTD
PMID:24865413
NCBI chr16:18,734,121...18,735,799
Ensembl chr16:18,734,122...18,735,799
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity
ISO
Sertraline results in decreased activity of KCNH2 protein
CTD
PMID:28551711
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Kcnj3
potassium inwardly-rectifying channel, subfamily J, member 3
multiple interactions
ISO
Sertraline inhibits the reaction [Ethanol results in increased activity of [KCNJ3 mRNA co-treated with KCNJ6 mRNA]]; Sertraline results in decreased activity of [KCNJ3 mRNA co-treated with KCNJ5 mRNA]; Sertraline results in decreased activity of [KCNJ3 mRNA co-treated with KCNJ6 mRNA]
CTD
PMID:22164246
NCBI chr 3:39,944,896...40,106,646
Ensembl chr 3:39,945,351...40,109,124
G
Kcnj5
potassium inwardly-rectifying channel, subfamily J, member 5
multiple interactions
ISO
Sertraline results in decreased activity of [KCNJ3 mRNA co-treated with KCNJ5 mRNA]
CTD
PMID:22164246
NCBI chr 8:30,724,923...30,753,083
Ensembl chr 8:30,724,925...30,753,518
G
Kcnj6
potassium inwardly-rectifying channel, subfamily J, member 6
multiple interactions
ISO
Sertraline inhibits the reaction [Ethanol results in increased activity of [KCNJ3 mRNA co-treated with KCNJ6 mRNA]]; Sertraline results in decreased activity of [KCNJ3 mRNA co-treated with KCNJ6 mRNA]
CTD
PMID:22164246
NCBI chr11:34,061,702...34,308,758
Ensembl chr11:34,061,708...34,308,758
G
Lhb
luteinizing hormone subunit beta
increases expression
EXP
Sertraline results in increased expression of LHB protein
CTD
PMID:29850907
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
G
Lss
lanosterol synthase
increases expression
ISO
Sertraline results in increased expression of LSS mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr20:12,091,138...12,118,858
Ensembl chr20:12,092,774...12,118,762
G
Maoa
monoamine oxidase A
multiple interactions
ISO
MAOA protein results in decreased amination of and results in increased metabolism of Sertraline
CTD
PMID:15547048
NCBI chr X:6,032,172...6,098,308
Ensembl chr X:6,030,795...6,099,593
G
Maob
monoamine oxidase B
multiple interactions
ISO
MAOB protein results in decreased amination of and results in increased metabolism of Sertraline
CTD
PMID:15547048
NCBI chr X:5,907,327...6,010,996
Ensembl chr X:5,907,266...6,011,003
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
increases lipidation multiple interactions
ISO
Sertraline results in increased lipidation of MAP1LC3B protein dorsomorphin inhibits the reaction [Sertraline results in increased lipidation of MAP1LC3B protein]
CTD
PMID:33124469
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690 Ensembl chr16:49,665,791...49,677,690
G
Map3k13
mitogen-activated protein kinase kinase kinase 13
increases expression
ISO
Sertraline results in increased expression of MAP3K13 mRNA
CTD
PMID:24865413
NCBI chr11:79,094,087...79,235,181
Ensembl chr11:79,097,247...79,235,181
G
Map3k8
mitogen-activated protein kinase kinase kinase 8
increases expression
ISO
Sertraline results in increased expression of MAP3K8 mRNA
CTD
PMID:24865413
NCBI chr17:53,382,908...53,403,216
Ensembl chr17:53,383,131...53,403,216
G
Map4k4
mitogen-activated protein kinase kinase kinase kinase 4
multiple interactions decreases expression
ISO
MAP4K4 mutant form inhibits the reaction [Sertraline results in increased cleavage of CASP4 protein]; MAP4K4 mutant form inhibits the reaction [Sertraline results in increased expression of DDIT3 protein]; MAP4K4 mutant form inhibits the reaction [Sertraline results in increased phosphorylation of EIF2AK3 protein] Sertraline results in decreased expression of MAP4K4 mRNA
CTD
PMID:24865413
NCBI chr 9:42,200,708...42,326,708
Ensembl chr 9:42,200,278...42,326,698
G
Mapk1
mitogen activated protein kinase 1
multiple interactions increases phosphorylation
EXP ISO
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Sertraline results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Sertraline results in increased phosphorylation of and results in increased activity of MAPK1 protein Sertraline results in increased phosphorylation of MAPK1 protein 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [Sertraline results in increased phosphorylation of MAPK1 protein]
CTD
PMID:17728140 PMID:24194395
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions increases phosphorylation
EXP ISO
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Sertraline results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Sertraline results in increased phosphorylation of and results in increased activity of MAPK3 protein Sertraline results in increased phosphorylation of MAPK3 protein
CTD
PMID:17728140 PMID:24194395
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
multiple interactions
EXP
pyrazolanthrone inhibits the reaction [Sertraline results in increased phosphorylation of and results in increased activity of MAPK8 protein]; Sertraline results in increased phosphorylation of and results in increased activity of MAPK8 protein
CTD
PMID:17728140
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mapk8ip3
mitogen-activated protein kinase 8 interacting protein 3
increases expression
ISO
Sertraline results in increased expression of MAPK8IP3 mRNA
CTD
PMID:24865413
NCBI chr10:13,918,417...13,958,335
Ensembl chr10:13,918,400...13,958,273
G
Mapt
microtubule-associated protein tau
multiple interactions
ISO
Chloroquine inhibits the reaction [Sertraline results in decreased expression of and results in decreased cleavage of MAPT protein]; dorsomorphin inhibits the reaction [Sertraline results in decreased expression of and results in decreased cleavage of MAPT protein]; Sertraline results in decreased expression of and results in decreased cleavage of MAPT protein
CTD
PMID:33124469
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
G
Mcl1
MCL1 apoptosis regulator, BCL2 family member
decreases expression
ISO
Sertraline results in decreased expression of MCL1 protein
CTD
PMID:24194395
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
G
Mtor
mechanistic target of rapamycin kinase
multiple interactions decreases phosphorylation
ISO
VDAC1 protein affects the reaction [Sertraline results in decreased phosphorylation of MTOR protein]
CTD
PMID:33124469
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Myc
MYC proto-oncogene, bHLH transcription factor
increases expression
ISO
Sertraline results in increased expression of MYC mRNA
CTD
PMID:24865413
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Nfe2l2
NFE2 like bZIP transcription factor 2
increases expression
ISO
Sertraline results in increased expression of NFE2L2 mRNA
CTD
PMID:24865413
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nfkb1
nuclear factor kappa B subunit 1
increases expression
ISO
Sertraline results in increased expression of NFKB1 mRNA
CTD
PMID:24865413
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nfkb2
nuclear factor kappa B subunit 2
increases expression
ISO
Sertraline results in increased expression of NFKB2 mRNA
CTD
PMID:24865413
NCBI chr 1:245,164,586...245,173,225
Ensembl chr 1:245,165,950...245,173,213
G
Nr0b2
nuclear receptor subfamily 0, group B, member 2
increases expression
ISO
Sertraline results in increased expression of NR0B2 mRNA
CTD
PMID:15342952
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
G
Nupr1
nuclear protein 1, transcriptional regulator
increases expression
ISO
Sertraline results in increased expression of NUPR1 mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr 1:181,213,292...181,215,327
Ensembl chr 1:181,213,368...181,215,281
G
Pecam1
platelet and endothelial cell adhesion molecule 1
decreases expression
ISO
Sertraline results in decreased expression of PECAM1 protein
CTD
PMID:15932816
NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116
G
Pf4
platelet factor 4
decreases expression
ISO
Sertraline results in decreased expression of PF4 protein
CTD
PMID:15932816
NCBI chr14:17,298,304...17,299,220
Ensembl chr14:17,298,308...17,299,365
G
Phyh
phytanoyl-CoA 2-hydroxylase
increases expression
ISO
Sertraline results in increased expression of PHYH mRNA
CTD
PMID:15342952
NCBI chr17:73,329,461...73,346,359
Ensembl chr17:73,329,082...73,346,409
G
Ppbp
pro-platelet basic protein
decreases expression
ISO
Sertraline results in decreased expression of PPBP protein
CTD
PMID:12912814
NCBI chr14:17,302,326...17,303,130
Ensembl chr14:17,302,326...17,303,130
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
increases expression
ISO
Sertraline results in increased expression of PPP1R15A mRNA
CTD
PMID:24865413
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
G
Ptgs2
prostaglandin-endoperoxide synthase 2
decreases expression
ISO
Sertraline results in decreased expression of PTGS2 mRNA; Sertraline results in decreased expression of PTGS2 protein
CTD
PMID:17499975
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Rbx1
ring-box 1
decreases expression
ISO
Sertraline results in decreased expression of RBX1 mRNA
CTD
PMID:24865413
NCBI chr 7:112,976,863...113,001,051
Ensembl chr 7:112,990,835...113,001,051
G
Relb
RELB proto-oncogene, NF-kB subunit
increases expression
ISO
Sertraline results in increased expression of RELB mRNA
CTD
PMID:24865413
NCBI chr 1:79,257,738...79,285,490
Ensembl chr 1:79,257,725...79,285,507
G
Rnf103
ring finger protein 103
increases expression
EXP
Sertraline results in increased expression of RNF103 mRNA
CTD
PMID:11071867
NCBI chr 4:103,526,456...103,542,529
Ensembl chr 4:103,526,502...103,555,919
G
Rps6ka3
ribosomal protein S6 kinase A3
decreases expression
ISO
Sertraline results in decreased expression of RPS6KA3 mRNA
CTD
PMID:24865413
NCBI chr X:35,517,306...35,623,296
Ensembl chr X:35,517,306...35,623,207
G
Rps6kb1
ribosomal protein S6 kinase B1
multiple interactions decreases phosphorylation
EXP ISO
Sertraline results in increased phosphorylation of and results in increased activity of RPS6KB1 protein; Sirolimus inhibits the reaction [Sertraline results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] Sertraline results in decreased phosphorylation of RPS6KB1 protein VDAC1 protein affects the reaction [Sertraline results in decreased phosphorylation of RPS6KB1 protein]
CTD
PMID:17728140 PMID:33124469
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
G
Sec61g
Sec61 translocon subunit gamma
decreases expression
ISO
Sertraline results in decreased expression of SEC61G mRNA
CTD
PMID:24865413
NCBI chr14:90,899,766...90,906,143
Ensembl chr14:90,899,768...90,906,162 Ensembl chr 9:90,899,768...90,906,162
G
Sele
selectin E
decreases expression
ISO
Sertraline results in decreased expression of SELE protein
CTD
PMID:12912814 PMID:15932816
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
G
Selenos
selenoprotein S
increases expression
ISO
Sertraline results in increased expression of SELS mRNA
CTD
PMID:24865413
NCBI chr 1:119,659,779...119,669,546
Ensembl chr 1:119,659,751...119,669,833
G
Selp
selectin P
decreases expression
ISO
Sertraline results in decreased expression of SELP protein
CTD
PMID:12912814 PMID:15932816
NCBI chr13:76,476,229...76,511,846
Ensembl chr13:76,476,295...76,511,845
G
Serpina3n
serpin family A member 3N
increases expression
ISO
Sertraline results in increased expression of SERPINA3 mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr 6:123,323,623...123,331,181
Ensembl chr 6:123,323,629...123,332,433
G
Serpini1
serpin family I member 1
increases expression
EXP
Sertraline results in increased expression of SERPINI1 mRNA
CTD
PMID:16637596
NCBI chr 2:160,346,403...160,433,135
Ensembl chr 2:160,346,758...160,433,135
G
Skp1
S-phase kinase-associated protein 1
decreases expression
ISO
Sertraline results in decreased expression of SKP1 mRNA
CTD
PMID:24865413
NCBI chr10:36,401,987...36,417,066
Ensembl chr10:36,402,153...36,417,388
G
Slc2a3
solute carrier family 2 member 3
decreases expression
ISO
Sertraline results in decreased expression of SLC2A3 mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr 4:155,960,944...156,026,000
Ensembl chr 4:155,960,946...156,025,472
G
Slc6a4
solute carrier family 6 member 4
multiple interactions affects binding increases expression decreases expression affects response to substance increases response to substance
ISO EXP
Sertraline inhibits the reaction [Monocrotaline results in increased expression of SLC6A4 mRNA] Sertraline binds to SLC6A4 protein Sertraline results in increased expression of SLC6A4 mRNA [Cannabidiol co-treated with Sertraline] results in increased expression of SLC6A4 mRNA Sertraline results in decreased expression of SLC6A4 protein SLC6A4 protein affects the susceptibility to Sertraline [Estradiol co-treated with Sertraline] affects the expression of SLC6A4 mRNA; [Sertraline results in decreased expression of SLC6A4 protein] which results in decreased metabolism of Selective Serotonin Reuptake Inhibitors; Estradiol promotes the reaction [Sertraline results in increased expression of SLC6A4 mRNA] SLC6A4 promoter polymorphism results in increased susceptibility to Sertraline
CTD
PMID:12151556 PMID:12955294 PMID:17042913 PMID:18650020 PMID:18923402 PMID:33124469 PMID:34262461 More...
NCBI chr10:61,824,208...61,858,924
Ensembl chr10:61,826,123...61,858,384
G
Sqstm1
sequestosome 1
increases expression multiple interactions
ISO
Sertraline results in increased expression of SQSTM1 protein aloxistatin promotes the reaction [Sertraline results in increased expression of SQSTM1 protein]
CTD
PMID:33124469
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
G
Ssr2
signal sequence receptor subunit 2
increases expression
ISO
Sertraline results in increased expression of SSR2 mRNA
CTD
PMID:24865413
NCBI chr 2:174,048,291...174,057,043
Ensembl chr 2:174,048,460...174,057,042
G
Star
steroidogenic acute regulatory protein
decreases expression
EXP
Sertraline results in decreased expression of STAR mRNA
CTD
PMID:29850907
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
G
Stat3
signal transducer and activator of transcription 3
decreases expression
ISO
Sertraline results in decreased expression of STAT3 mRNA; Sertraline results in decreased expression of STAT3 protein
CTD
PMID:17499975
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Stk11
serine/threonine kinase 11
increases phosphorylation
ISO
Sertraline results in increased phosphorylation of STK11 protein
CTD
PMID:33124469
NCBI chr 7:9,574,553...9,591,315
Ensembl chr 7:9,575,269...9,591,315
G
Stmn1
stathmin 1
decreases expression
ISO
Sertraline results in decreased expression of STMN1 mRNA
CTD
PMID:24865413
NCBI chr 5:146,680,757...146,687,154
Ensembl chr 5:146,681,436...146,687,154
G
Syvn1
synoviolin 1
increases expression
ISO
Sertraline results in increased expression of SYVN1 mRNA
CTD
PMID:24865413
NCBI chr 1:203,339,235...203,346,137
Ensembl chr 1:203,339,619...203,346,152
G
Tagln
transgelin
decreases expression
ISO
Sertraline results in decreased expression of TAGLN mRNA
CTD
PMID:15342952
NCBI chr 8:46,224,939...46,230,413
Ensembl chr 8:46,222,472...46,230,668
G
Taok2
TAO kinase 2
increases expression
ISO
Sertraline results in increased expression of TAOK2 mRNA
CTD
PMID:24865413
NCBI chr 1:181,475,708...181,494,738
Ensembl chr 1:181,475,711...181,494,613
G
Tfap2a
transcription factor AP-2 alpha
increases expression
ISO
Sertraline results in increased expression of TFAP2A protein
CTD
PMID:28844482
NCBI chr17:24,028,716...24,047,507
Ensembl chr17:24,024,432...24,047,507
G
Tnf
tumor necrosis factor
decreases secretion increases expression
ISO
Sertraline results in decreased secretion of TNF protein Sertraline results in increased expression of TNF mRNA
CTD
PMID:17499975 PMID:24194395 PMID:24865413
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tph2
tryptophan hydroxylase 2
multiple interactions increases expression increases activity
EXP
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Sertraline results in increased expression of TPH2 mRNA] Sertraline results in increased expression of TPH2 mRNA; Sertraline results in increased expression of TPH2 protein Sertraline results in increased activity of TPH2 protein
CTD
PMID:11901216
NCBI chr 7:50,685,694...50,789,424
Ensembl chr 7:50,685,694...50,789,424
G
Txndc5
thioredoxin domain containing 5
decreases expression
ISO
Sertraline results in decreased expression of TXNDC5 mRNA
CTD
PMID:24865413
NCBI chr17:26,289,880...26,318,025
Ensembl chr17:26,289,880...26,318,025
G
Ube2d2b
ubiquitin-conjugating enzyme E2D 2B
decreases expression
ISO
Sertraline results in decreased expression of UBE2D4 mRNA
CTD
PMID:24865413
NCBI chr14:1,915,999...1,917,473
Ensembl chr14:1,916,845...1,917,416
G
Ube2g1
ubiquitin-conjugating enzyme E2G 1
decreases expression
ISO
Sertraline results in decreased expression of UBE2G1 mRNA
CTD
PMID:24865413
NCBI chr10:57,225,963...57,306,748
Ensembl chr10:57,225,952...57,308,568
G
Ube4b
ubiquitination factor E4B
decreases expression
ISO
Sertraline results in decreased expression of UBE4B mRNA
CTD
PMID:24865413
NCBI chr 5:159,766,829...159,870,509
Ensembl chr 5:159,766,829...159,870,509
G
Ubqln1
ubiquilin 1
increases expression
ISO
Sertraline results in increased expression of UBQLN1 mRNA
CTD
PMID:24865413
NCBI chr17:6,439,002...6,477,096
Ensembl chr17:6,439,002...6,477,090
G
Ugt2b7
UDP glucuronosyltransferase family 2 member B7
multiple interactions
ISO
UGT2B7 protein results in increased glucuronidation of and results in increased metabolism of Sertraline
CTD
PMID:15547048
NCBI chr14:20,896,682...20,919,604
Ensembl chr14:20,896,682...20,919,604
G
Vcam1
vascular cell adhesion molecule 1
increases expression
ISO
Sertraline results in increased expression of VCAM1 protein
CTD
PMID:15932816
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
G
Vdac1
voltage-dependent anion channel 1
multiple interactions affects binding
ISO
VDAC1 protein affects the reaction [Sertraline results in decreased phosphorylation of MTOR protein]; VDAC1 protein affects the reaction [Sertraline results in decreased phosphorylation of RPS6KB1 protein] Sertraline binds to VDAC1 protein
CTD
PMID:33124469
NCBI chr10:36,532,306...36,559,642
Ensembl chr10:36,532,244...36,559,640
G
Wipi1
WD repeat domain, phosphoinositide interacting 1
increases expression
ISO
Sertraline results in increased expression of WIPI1 mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr10:94,542,946...94,580,174
Ensembl chr10:94,542,946...94,579,846
G
Xbp1
X-box binding protein 1
increases splicing
ISO
Sertraline results in increased splicing of XBP1 mRNA
CTD
PMID:24865413
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all